Childhood Cancers

From Colin McFarlane and John Homme opening up about their cancer diagnoses to Pope Francis visiting a pediatric oncology ward, here’s what’s happening in the cancer space this week.

Childhood cancer survivors tend to die of the same factors as the general population, though at an earlier age. Research showed, though, that these risks can be modified.

The Food and Drug Administration approved Keytruda for adult and pediatric patients with previously treated unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors.

This approval is the first of its kind as a first-line systemic therapy for pediatric patients with low-grade gliomas of a specific mutation.

Even after my son survived cancer, I still had fears — and nightmares — of the worst.

The Food and Drug Administration is reviewing remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease.

Latino patients with acute lymphoblastic leukemia and a high level of serum creatine may have an almost six-fold increased risk of neurotoxicity.

The impact of living in a socioeconomically disadvantaged area and having conditions like diabetes or high blood pressure may increase the likelihood of a childhood cancer survivor dying at least five years after they were diagnosed.

Survivors of childhood cancer tended to have a higher rate of clonal hematopoiesis than those without a cancer history, research showed.

When children with cancer received dexrazoxane alongside their chemotherapy, they tended to have fewer heart complications in the short and long term.

From funding updates on the Cancer Moonshot to Howie Rose’s bladder cancer diagnosis and more, here’s what’s happening in the oncology space this week.

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

Immune-based therapies have not been as successful in childhood cancer as they have been with adults, but ongoing research is hoping to change that.

As young adults, survivors of childhood cancers were more likely to report feeling lonely compared with their siblings, emphasizing the importance of screening.

From the cancer diagnoses of an MLB pitcher and star of Riverdance to First Lady Jill Biden’s recent carcinoma removal, here’s what’s happening in the cancer space this week.

Tiffany Williams devoted her career as a pediatric nurse practitioner to addressing health disparities among children and teens. But then, just a year after earning her doctorate, she received a diagnosis of multiple myeloma.

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study findings showed.

There were some monumental FDA approvals in the cancer space during 2022 — here’s a roundup of our most-read agency decisions of the year.

From Tina Turner’s son, Ronnie, dying of cancer to the Miami Dolphins honoring a group of people who raised over $5 million for oncology care and research, here is what’s happening in the cancer space this week.

The treatment and support that children with cancer receive has advanced over the past 20 years, but more progress to improve the cure rate is on the horizon.

Tecentriq was approved by the FDA for adults and children aged two years and older with advanced alveolar soft part sarcoma, a disease typically diagnosed in approximately 80 patients per year in the U.S.

Children with acute lymphoblastic leukemia had a 2.4-fold greater risk of relapse if they were considered extremely obese while undergoing maintenance therapy.

Childhood cancer survivors who had high daily sugar intake — especially when it came to sweetened beverages — had an increased risk of premature aging-related health complications, according to recent research.

Though remission rates for children who underwent CAR-T cell therapy did not differ based on socioeconomic status, accessibility gaps remain.

The Food and Drug Administration approved Adcetris plus chemotherapy for pediatric patients with classical high-risk Hodgkin lymphoma.

Members of the FDA’s Oncologic Drug Advisory Committee voted that there was insufficient evidence claiming that omburtamab improved survival in patients with neuroblastoma with central nervous system/leptomeningeal metastases.

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

Childhood cancer survivors should be aware of any symptoms they experience during survivorship and communicate those with their care team.

The use of a multi-agent chemotherapy regimen resulted in improved outcomes in a group of children with pleuropulmonary blastoma, a rare form of lung cancer, when compared with other regimens.

The Food and Drug Administration approved Pedmark for the prevention of chemotherapy-induced hearing loss in pediatric patients with localized, nonmetastatic solid cancers.